Yvonne Shutack

2.2k total citations
6 papers, 212 citations indexed

About

Yvonne Shutack is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Yvonne Shutack has authored 6 papers receiving a total of 212 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Surgery, 2 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Yvonne Shutack's work include Neuroendocrine Tumor Research Advances (2 papers), Pancreatic and Hepatic Oncology Research (1 paper) and Nanoparticle-Based Drug Delivery (1 paper). Yvonne Shutack is often cited by papers focused on Neuroendocrine Tumor Research Advances (2 papers), Pancreatic and Hepatic Oncology Research (1 paper) and Nanoparticle-Based Drug Delivery (1 paper). Yvonne Shutack collaborates with scholars based in United States and India. Yvonne Shutack's co-authors include Nadira Yuldasheva, Michelle Eugeni, Geoffrey Seidel, Steven K. Libutti, H. Richard Alexander, James F. Pingpank, Shane Y. Morita, David L. Bartlett, Joseph Blansfield and G.M. Glenn and has published in prestigious journals such as Journal of Clinical Oncology, Surgery and Journal of Surgical Research.

In The Last Decade

Yvonne Shutack

6 papers receiving 202 citations

Peers

Countries citing papers authored by Yvonne Shutack

Since Specialization

Citations

This map shows the geographic impact of Yvonne Shutack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yvonne Shutack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yvonne Shutack more than expected).

Fields of papers citing papers by Yvonne Shutack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yvonne Shutack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yvonne Shutack. The network helps show where Yvonne Shutack may publish in the future.

Co-authorship network of co-authors of Yvonne Shutack

This figure shows the co-authorship network connecting the top 25 collaborators of Yvonne Shutack. A scholar is included among the top collaborators of Yvonne Shutack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yvonne Shutack. Yvonne Shutack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

#	Work	Indexed citations
1	A Phase II Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Adrenocortical Carcinoma 2018 ·Journal of Surgical Research ·Marybeth S. Hughes, Winifred Lo, Tatiana Beresnev, Maria J. Merino, Yvonne Shutack, R. Taylor Ripley, Jonathan M. Hernandez, Jeremy L. Davis	8
2	Duodenal ischemia and upper GI bleeding are dose-limiting toxicities of 24-h continuous intra-arterial pancreatic perfusion of gemcitabine following vascular isolation of the pancreatic head: early results from the Regional Chemotherapy in Locally Advanced Pancreatic Cancer (RECLAP) study 2014 ·Investigational New Drugs ·Joal D. Beane, (unknown), Elliot Levy, Prakash K. Pandalai, Bradford J. Wood, Nadine Abi‐Jaoudeh, Tatiana Beresnev, Yvonne Shutack, (unknown), Itzhak Avital, Udo Rudloff	9
3	A randomized phase II trial comparing two doses of lenalidomide for the treatment of stage IV ocular melanoma 2009 ·Journal of Clinical Oncology ·Jerome B. Zeldis, (unknown), Geoffrey Seidel, Nadira Yuldasheva, D. Stirling, Yvonne Shutack, Steven K. Libutti	6
4	Clinical, genetic and radiographic analysis of 108 patients with von Hippel-Lindau disease (VHL) manifested by pancreatic neuroendocrine tumors (PNETs) 2007 ·Surgery ·Joseph Blansfield, (unknown), Shane Y. Morita, Peter L. Choyke, James F. Pingpank, H. Richard Alexander, Geoffrey Seidel, Yvonne Shutack, Nadira Yuldasheva, Michelle Eugeni, David L. Bartlett, G.M. Glenn, Lindsay Middelton, W. Marston Linehan, Steven K. Libutti	172
5	Preliminary results of a phase I clinical trial of CYT-6091: A pegylated colloidal gold-TNF nanomedicine 2007 ·Journal of Clinical Oncology ·S. K. Libutti, Giulio F. Paciotti, (unknown), (unknown), William E. Gannon, Michelle Eugeni, (unknown), Yvonne Shutack, Nadira Yuldasheva, Lawrence Tamarkin	15
6	A pilot study of local injection of TNFerade biologic in addition to neo-adjuvant chemoradiation for the treatment of primary and recurrent rectal cancer 2007 ·Journal of Clinical Oncology ·Kevin Camphausen, Martha Quezado, Deborah E. Citrin, James F. Pingpank, Bradford J. Wood, H. Richard Alexander, Geoffrey Seidel, Michelle Eugeni, Yvonne Shutack, Steven K. Libutti	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact